Lexicon Pharmaceuticals
LXRX
LXRX
119 hedge funds and large institutions have $1.15B invested in Lexicon Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 41 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $1.29B → $1.15B (-$143M)
20% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 41
22% less call options, than puts
Call options by funds: $3.33M | Put options by funds: $4.29M
Holders
119
Holding in Top 10
3
Calls
$3.33M
Puts
$4.29M
Top Buyers
| 1 | +$13.8M | |
| 2 | +$5.65M | |
| 3 | +$1.76M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.52M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.46M |
Top Sellers
| 1 | -$6.59M | |
| 2 | -$3.96M | |
| 3 | -$3.69M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.93M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.82M |